Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.83), $0.07 worse than the analyst estimate of ($0.76). Revenue for the quarter came in at $4.13 million versus the consensus estimate of $855.71 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.